Por favor, use este identificador para citar o enlazar este ítem:https://uvadoc.uva.es/handle/10324/82635
Título
Role of the Furosemide Stress Test in Renal Injury Prognosis
Autor
Año del Documento
2020
Editorial
MDPI, Basel, Switzerland.
Descripción
Producción Científica
Documento Fuente
Coca, A., Aller, C., Reinaldo Sánchez, J., Valencia, A. L., Bustamante-Munguira, E., & Bustamante-Munguira, J. (2020). Role of the Furosemide Stress Test in Renal Injury Prognosis. International journal of molecular sciences, 21(9), 3086. https://doi.org/10.3390/ijms21093086
Resumen
Risk stratification and accurate patient prognosis are pending issues in the management of patients with kidney disease. The furosemide stress test (FST) has been proposed as a low-cost, fast, safe, and easy-to-perform test to assess tubular integrity, especially when compared to novel plasma and urinary biomarkers. However, the findings regarding its clinical use published so far provide insufficient evidence to recommend the generalized application of the test in daily clinical routine. Dosage, timing, and clinical outcomes of the FST proposed thus far have been significantly different, which further accentuates the need for standardization in the application of the test in order to facilitate the comparison of results between series. This review will summarize published research regarding the usefulness of the FST in different settings, providing the reader some insights about the possible implications of FST in clinical decision-making in patients with kidney disease and the challenges that research will have to address in the near future before widely applying the FST
Palabras Clave
acute kidney injury; functional assessment; furosemide stress test; renal biomarkers
Revisión por pares
SI
Idioma
eng
Tipo de versión
info:eu-repo/semantics/publishedVersion
Derechos
openAccess
Aparece en las colecciones
Ficheros en el ítem
Tamaño:
17.03Mb
Formato:
Adobe PDF
Descripción:
Artículo principal








